Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Vagus nerve Stories

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-04 08:36:10

HOUSTON, Feb. 4, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the third quarter ended January 24, 2014, of its fiscal year ending April 25, 2014, on Thursday, February 20, 2014, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2014 Third Quarter Results Webcast and Conference Call...

2014-01-23 23:24:30

According to Ron Minson, MD, Clinical Director at Integrated Listening Systems (iLs), the manufacturer of the Dreampad, a pilot study measuring the ability of a new product, a pillow which delivers music through vibration, indicates it may help those challenged by stress-related symptoms. Over 80% of those in the study showed a significant relaxation response within 15 minutes of using the pillow. Denver, CO (PRWEB) January 23, 2014 Preliminary research measuring the effect of new...

2013-12-08 12:21:25

Investigators present results at the American Epilepsy Society (AES) meeting in Washington, DC HOUSTON, Dec. 8, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C. Paul Boon, M.D., Ph.D., Senior Full Professor of Neurology and Director of Ghent Institute for...

2013-12-05 08:29:20

HOUSTON, Dec 5, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that, following substantial completion of its prior share repurchase program, its board of directors has approved a new share repurchase program of one million shares. The company's board of directors had previously authorized repurchases of shares in February 2008, February 2010, June 2011, November 2011 and January 2013. Since February 2008, and through December 3, 2013, the company has...

2013-11-25 08:28:01

HOUSTON, Nov. 25, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 25(th) Annual Piper Jaffray Healthcare Conference on Tuesday, December 3, 2013, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 2:30 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link...

2013-11-21 16:27:08

HOUSTON, Nov. 21, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that it will provide a webcast of the presentations at its investor and analyst meeting, which will be held on Thursday, December 5, 2013, from 8:30 am until approximately 12:00 pm Eastern Time. To access the live webcast, please enter the Company's website at http://www.cyberonics.com, and follow the webcast link listed under Investor Relations, Events and Presentations. A replay of the presentations and...

2013-11-21 11:33:22

UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial. Drs. Sven Vanneste and Michael Kilgard of the School of Behavioral and Brain Sciences used a new method pairing vagus nerve stimulation (VNS) with auditory tones to alleviate the symptoms of chronic tinnitus. Their results were published on Nov. 20 in the...

2013-11-07 08:33:35

HOUSTON, Nov. 7, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that the company will report financial results for the second quarter ended October 25, 2013, of its fiscal year ending April 25, 2014, on Thursday, November 21, 2013, before regular market trading hours. The company will conduct a conference call to discuss those results on the same day at 8:00 AM Central Time (9:00 AM Eastern Time). Fiscal Year 2014 Second Quarter Results Webcast and Conference...